Advertisement
Europe
Subscribe to Europe

The Lead

Italy's Ebola Patient Gets Experimental Treatment

November 25, 2014 11:35 am | News | Comments

An Italian doctor who contracted Ebola while working in Sierra Leone has arrived back in Italy and is being treated with the same experimental drugs used in the U.S. and other European countries to treat people infected with the virus.   

EMA: No Consistent Evidence of an Increased Risk of Heart Problems with Testosterone Medicines

November 21, 2014 8:13 am | News | Comments

The CMDh, a regulatory body representing EU Member States, has agreed by consensus that there is...

German Court: e-Cigarette Liquids Not Medicines

November 20, 2014 3:32 pm | News | Comments

A German federal court has ruled that the liquids contained in e-cigarettes aren't medicinal...

British, Dutch Kill Poultry to Fight Bird Flu

November 18, 2014 8:43 am | by GREGORY KATZ, Associated Press | News | Comments

Chickens were being killed in the Netherlands, and Britain was preparing to kill ducks, after...

View Sample

FREE Email Newsletter

Heart Stents May Require Longer Blood Thinner Use

November 18, 2014 8:37 am | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

Millions of people with stents that prop open clogged heart arteries may need anti-clotting drugs much longer than the one year doctors recommend now. A large study found that continuing for another 18 months lowers the risk of heart attacks, clots and other problems.

BMS to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland

November 17, 2014 8:31 am | News | Comments

Bristol-Myers Squibb Company has announced plans to construct a new state-of-the-art, large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland, that will produce multiple therapies for the company’s growing biologics portfolio.

Orexigen Rises as Weight Loss Drug Review Proceeds

November 10, 2014 2:24 pm | News | Comments

Shares of Orexigen Therapeutics jumped Monday after the company said a European Union review of its weight loss drug Contrave, which was approved in the U.S. in September, is progressing on schedule.         

Advertisement

EMA Advises on Development Plan for GSK Ebola Vaccine

October 29, 2014 11:15 am | News | Comments

The European Medicines Agency (EMA) has given scientific advice to GSK on its development plan for an Ebola vaccine. This is the first time in the current Ebola outbreak that EMA has given ‘rapid scientific advice’ using an accelerated procedure.

Sanofi Ousts CEO Amid Pressure Over Diabetes Drug

October 29, 2014 8:08 am | by GREG KELLER, Associated Press | News | Comments

Sanofi sacked its CEO Wednesday following a board room rift over the handling of one of France's largest publicly traded companies. Christopher Viehbacher, the first non-Frenchman to lead Sanofi, was dismissed after six years running the company that traces its roots to the early 19th century.

Sanofi Shares Plunge Due to Diabetes Drug Pricing Pressures

October 28, 2014 8:20 am | News | Comments

Sanofi saw its stock price plunge today after it reported a slide in quarterly earnings and warned of pricing pressure on its blockbuster diabetes treatment in the U.S. Sanofi shares fell 8.4 percent to 76.39 euros, forfeiting gains in the run-up to the announcement.

Swissmedic Approves Trial for Ebola Vaccine

October 28, 2014 7:35 am | by The Associated Press | News | Comments

The Swiss agency that regulates new drugs has approved an application for a clinical trial with an experimental Ebola vaccine at the Lausanne University Hospital. Swissmedic said the trial will be conducted among 120 volunteer participants with support from the U.N. World Health Organization.

Novartis Posts Strong Profit

October 28, 2014 7:35 am | by The Associated Press | News | Comments

Novartis AG has posted a 45 percent rise in net profit in the third quarter, boosted by strong sales of new products such as Gilenya for multiple sclerosis and the leukemia drug Tasigna. The Basel, Switzerland-based company's reported quarterly net profit was $3.24B

Advertisement

Roche Announces Plans for Future Investments at its Basel Site

October 22, 2014 8:46 am | News | Comments

Over the next 10 years, Roche will invest 3 billion Swiss francs in the construction of a new research and development centre for around 1,900 employees, in a state-of-the-art office building for up to 1,700 employees, in upgrading infrastructure, and in renovating the historic office building designed by Otto R. Salvisberg.

German Firm Wins Appeal in Spain Thalidomide Case

October 22, 2014 8:13 am | News | Comments

A Spanish court has upheld an appeal by a German pharmaceutical company, ditching a previous ruling that ordered the company to pay compensation to 22 Spaniards who blame their disabilities on the drug thalidomide.      

EU Seeks $1.27B in Ebola Aid for West Africa

October 20, 2014 2:19 pm | by RAF CASERT, Associated Press | News | Comments

The European Union committed itself to step up efforts toward getting 1 billion euros ($1.27 billion) in aid to fight Ebola in West Africa and rejected the idea of halting direct flights coming from the region.       

Roche Posts Flat Nine-Month Sales

October 16, 2014 8:14 am | by JOHN HEILPRIN, Associated Press | News | Comments

Roche Holding AG posted flat sales for the first nine months of 2014, but said Thursday the results show strong demand for its cancer drugs and emerging new products.              

Ireland Plans Growth Budget After Six Years of Austerity

October 14, 2014 8:11 am | by SHAWN POGATCHNIK, Associated Press | News | Comments

Finance Minister Michael Noonan and Public Expenditure Minister Brendan Howlin are unveiling a 2015 budget Tuesday expected to contain around 1 billion euros ($1.3 billion) in income tax breaks and spending increases, ending a seven-budget run that slashed 30 billion euros from the economy.

Advertisement

Endo to Buy Auxilium in Deal Worth $2.6B

October 9, 2014 7:46 am | by The Associated Press | News | Comments

Ireland's Endo International is buying Auxilium Pharmaceuticals Inc. in a sweetened cash-and-stock deal valued at $2.6 billion a few weeks after Auxilium rejected a lower bid for the company. Endo says it will pay $33.25 in cash and stock for each Auxilium share.

Nurse in Spain Gets Ebola, Raising Global Concern

October 7, 2014 8:11 am | by CIARAN GILES, Associated Press; MIKE STOBBE, Associated Press | News | Comments

In a case underscoring the perils of caring for Ebola patients, a nurse in Spain who cared for an Ebola patient has come down with the disease — the first known transmission outside West Africa during the current epidemic.     

Overseas Deal Rules End One Combo, Alter Another

October 3, 2014 1:46 pm | by Tom Murphy - AP Business Writer - Associated Press | News | Comments

New government rules aimed at curbing overseas deals that cut corporate taxes appear to be working, just not entirely the way regulators intended.                  

EU OKs Eli Lilly's $5.4B Bid for Novartis division

October 3, 2014 6:47 am | by The Associated Press | News | Comments

The European Union's antitrust authority says it has approved the $5.4 billion sale of Novartis' animal health division to U.S. pharmaceutical firm Eli Lilly. The 28-nation bloc's executive Commission said Friday the sale won't hinder competition because the merged firm will continue to face a number of strong competitors.

West to Build Pharmaceutical Component Manufacturing Plant in Ireland

October 2, 2014 8:09 am | News | Comments

West Pharmaceutical Services announced today it plans to expand its global manufacturing operations to include a new site in Waterford, Ireland. The new facility will produce packaging components for insulin injector cartridges and other high-value packaging components, in order to meet growing demand from pharmaceutical and biotech customers.

Capsugel Awarded EXCiPACT™ Certifications for Excipient Good Manufacturing Practices

October 1, 2014 10:33 am | News | Comments

Capsugel announced today that it has received EXCiPACT™ certification for its sites in Bornem, Belgium, and Colmar, France. The certification provides independent validation that Capsugel maintains excipient Good Manufacturing Practices (GMPs) and complies with current European Union regulations in the manufacturing of empty, two-piece hard capsules.

Optel Vision to Create 140 New Jobs in Major Expansion in Limerick

October 1, 2014 9:00 am | News | Comments

Ireland's Minister for Jobs, Enterprise & Innovation, Richard Bruton TD, today announced that Optel Vision, a Canadian company specializing in Track & Trace and vision inspection solutions for the manufacturing industries, is to create 140 new jobs in Limerick as part of a new European expansion.

Jacobs Receives Pharmaceuticals Pilot Plant Contract from Novo Nordisk

October 1, 2014 8:44 am | News | Comments

Under the terms of the contract, Jacobs is providing engineering, procurement and construction management services for a new purification pilot plant project, which initially involves one purification line. The project is expected to expand Novo Nordisk’s capacity to produce active pharmaceutical ingredients for a growing number of diabetes drugs in development.

New EU Trade Chief Seeks Reset in US Trade Talks

September 29, 2014 1:29 pm | by JUERGEN BAETZ, Associated Press | News | Comments

Acknowledging strong public skepticism in Europe over free trade talks with the U.S., the European Union's incoming trade chief on Monday called for a "fresh start" and more transparency in the negotiations.        

Report Shows Discrepancies In Access to Cancer Drugs

September 26, 2014 10:41 am | News | Comments

Access to potentially life-extending cancer drugs varies significantly in different regions of the world, two new studies show. Researchers say the results demonstrate the need for better collaboration between doctors and health authorities on an international scale, to ensure patients have access to the best treatments.

Limits on Overseas Mergers Prompt Renewed Debate

September 23, 2014 8:05 am | by JOSH LEDERMAN, Associated Press; JIM KUHNHENN, Associated Press | News | Comments

The Obama administration's decision to curb the ability of U.S. corporations to skirt taxes by merging with foreign companies kicked off an immediate election-season debate over when and how to tackle the nation's complex corporate tax code.  

Merck KGaA to Buy Sigma Aldrich for $17B

September 22, 2014 7:44 am | by David Mchugh - AP Business Writer - Associated Press | News | Comments

Merck says it has agreed to buy St. Louis-based chemical firm Sigma-Aldrich Corp. for $17 billion. Darmstadt-based Merck KGaA said Monday it is paying $140 per share in cash for all of Sigma-Aldrich's shares — a premium of 37 percent over Friday's closing price of $102.37.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading